MedCap AB (publ) (STO:MCAP)

Market Cap	7.47B +11.5%
Revenue (ttm)	2.18B +18.0%
Net Income	225.20M +11.5%
EPS	15.00 +10.4%
Shares Out	15.02M
PE Ratio	33.16
Forward PE	21.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,937
Open	502.50
Previous Close	497.40
Day's Range	491.00 - 517.00
52-Week Range	403.00 - 677.00
Beta	0.50
Analysts	Strong Buy
Price Target	617.50 (+24.15%)
Earnings Date	Jul 21, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 637
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.